Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Return on Equity (2022 - 2025)

Bioregenx (BRGX) has 4 years of Return on Equity data on record, last reported at 5.18% in Q3 2025.

  • For Q3 2025, Return on Equity rose 553.0% year-over-year to 5.18%; the TTM value through Sep 2025 reached 5.18%, up 553.0%, while the annual FY2024 figure was 8.46%, 816.0% up from the prior year.
  • Return on Equity reached 5.18% in Q3 2025 per BRGX's latest filing, down from 5.33% in the prior quarter.
  • Across five years, Return on Equity topped out at 5.81% in Q1 2025 and bottomed at 4.53% in Q4 2024.
  • Average Return on Equity over 4 years is 0.92%, with a median of 0.22% recorded in 2023.
  • Peak YoY movement for Return on Equity: tumbled -481bps in 2024, then soared 632bps in 2025.
  • A 4-year view of Return on Equity shows it stood at 0.06% in 2022, then soared by 397bps to 0.29% in 2023, then crashed by -1686bps to 4.53% in 2024, then skyrocketed by 214bps to 5.18% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 5.18% in Q3 2025, 5.33% in Q2 2025, and 5.81% in Q1 2025.